Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.7B | 7.1B | 6.0B | 7.2B |
Cost of revenue | 1.9B | 1.5B | 1.3B | 1.5B |
Gross profit | 4.8B | 5.5B | 4.7B | 5.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | 628M | — | 613M |
Operating income | 458M | 563M | 859M | 519M |
Non operating interest income | ||||
Income | 31M | 110M | — | 62M |
Expense | 112M | 167M | — | 130M |
Other income expense | — | — | — | — |
Pretax income | 335M | 487M | 204M | 473M |
Tax provision | 84M | 134M | 55M | 96M |
Net income | 251M | 354M | 149M | 377M |
Basic EPS | 2.2 | 3.1 | 1.3 | 3.3 |
Diluted EPS | 2.2 | 3.1 | 1.3 | 3.3 |
Basic average shares | 113.3M | 113.3M | 113.3M | 113.3M |
Diluted average shares | 113.3M | 113.3M | 113.3M | 113.3M |
EBITDA | 705M | 875M | 1.1B | 805M |
Net income from continuing op. | 335M | 487M | 204M | 473M |
Minority interests | -1M | -6M | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |